Antiphospholipid antibody syndrome is a well-recognized cause of hypercoagulability and
has multiple manifestations. Patients with an unexplained thrombotic event should be …

Antiphospholipid antibody syndrome is defined by the presence of thromboembolic
complications and/or pregnancy morbidity in the presence of persistently increased titers of …

The antiphospholipid syndrome (APS) was reported in the early 1980s as the association of
thrombosis, recurrent pregnancy loss in the presence of anticardiolipin antibodies (aCL) …

Indefinite anticoagulation remains the mainstay of treatment for thrombotic APS. Despite
advances in diagnostic techniques, it remains difficult to predict thrombotic risk in …

Background The antiphospholipid-antibody syndrome is a thrombophilic disorder in which
venous or arterial thrombosis, or both, may occur in patients with antiphospholipid …

Antiphospholipid antibody syndrome (APS) is an autoantibody-mediated thrombophilic
disorder that causes a hypercoagulable state and can lead to venous thromboembolism …

Opinion statement Antiphospholipid antibody syndrome (APS) is a recently defined
autoimmune disorder characterized by recurrent vascular thromboses or recurrent …

Antiphospholipid antibody syndrome (APS) is now recognized as one of the most important
causes of hypercoagulability. Hypercoagulable states can occur in both primary (genetic) …

Recommendations for the management of thrombosis in the antiphospholipid antibody
syndrome have been based largely on retrospective case series. Several clinical trials have …

The antiphospholipid antibody syndrome (APS) is defined by the persistent presence of
antiphospholipid antibodies in patients with recurrent venous or arterial thromboembolism or …